Wada Y, Pierce M L, Fujinami R S
Department of Neurology, University of Utah, Salt Lake City.
J Virol. 1994 Feb;68(2):1219-23. doi: 10.1128/JVI.68.2.1219-1223.1994.
We constructed a Theiler's virus mutant designated DA3304, in which the amino acid at position 101 of VP1 was changed from a threonine to an alanine. Because of this single amino acid change, DA3304 could still produce a biphasic central nervous system disease similar to that produced by the wild-type DA virus. However, DA3304 was significantly attenuated in both the acute and the chronic phases and induced smaller demyelinating lesions than the wild-type DA virus. The data are most compatible with the attenuated phenotype in DA3304 being due to the change of binding efficiency between the virus and receptor resulting from the physical alteration at the mutation site.
我们构建了一种名为DA3304的泰勒氏病毒突变体,其中VP1蛋白第101位的氨基酸由苏氨酸变为丙氨酸。由于这一单氨基酸变化,DA3304仍可引发与野生型DA病毒所致相似的双相中枢神经系统疾病。然而,DA3304在急性期和慢性期均显著减毒,且比野生型DA病毒诱导产生的脱髓鞘损伤更小。这些数据最符合DA3304的减毒表型是由于突变位点的物理改变导致病毒与受体之间结合效率变化的观点。